Return On Equity	(Mar 31 2026) 2026	(Mar 31 2025) 2025	(Mar 31 2024) 2024	(Mar 31 2023) 2023	(Mar 31 2022) 2022
Y / Y Equity Change	-29.83 %	-28.12 %	-23.07 %	-8.28 %	62.17 %
Y / Y Net Income Change	-	-	-	-	-
Return On Equity	0.1 %	-	-	-	-

SNOA all Ratios >> Back to SNOA Management Effectiveness >> See Quarterly SNOA Return On Equity

You need to upgrade your Flash Player

Roe Comment

In (Mar 31 2026) ROE improved to 0.1 % compare to previous year, due to net income growth.

Financial Statements
Sonoma Pharmaceuticals Inc 's Equity	$ 3 Millions	Annual SNOA's Balance sheet
Sonoma Pharmaceuticals Inc 's Annual Income	$ 0 Millions	Annual SNOA's Income Statement
Where are SNOA's Income coming from?		Visit SNOA's Income by Segment

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.